Suk-Young Yoo

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial

Alexander Stratigos, Aleksandar Sekulić, Ketty Peris et al. · The Lancet Oncology · 2021 · 266 citations · Full text

Medicine, Hedgehog Inhibitor Therapy, Dermatology +5

Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice

Kwang Hwa Jung, Wonbeak Yoo, Heather L. Stevenson et al. · Clinical Cancer Research · 2017 · 121 citations · Full text

Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

Danny Rischin, Nikhil I. Khushalani, Chrysalyne D. Schmults et al. · Journal for ImmunoTherapy of Cancer · 2021 · 101 citations · Full text

Cancer Management, Median Time, Dermatology +16

Transcriptomic Architecture of the Adjacent Airway Field Cancerization in Non–Small Cell Lung Cancer

Humam Kadara, Junya Fujimoto, Suk-Young Yoo et al. · JNCI Journal of the National Cancer Institute · 2014 · 84 citations · Full text

KEAP1-Dependent Synthetic Lethality Induced by AKT and TXNRD1 Inhibitors in Lung Cancer

Bingbing Dai, Suk-Young Yoo, Geoffrey Bartholomeusz et al. · Cancer Research · 2013 · 77 citations · Full text